查和产后抑郁症的新治疗方法
Journal of obstetric, gynecologic, and neonatal nursing : JOGNN
|October 8, 2023
概括
美国食品和药物管理局于2023年8月批准了Zurzuvae (祖拉诺),标志着治疗产后抑郁症的第一个口服药物. 这突显了治疗围产期抑郁症的进展,这种抑郁症仍未被充分发现和治疗.
科学领域:
- 产科和妇科 产科和妇科
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 围产期抑郁症,包括怀孕期间和产后的抑郁症,是严重的公共卫生问题.
- 尽管现有的查和治疗建议,但围产期抑郁症仍未得到充分发现和治疗.
- 最近美国食品和药物管理局批准Zurzuvae (苏拉诺) 提供了一个新的药理选择.
结论:
- 祖拉诺的批准代表了产后抑郁症药理治疗选择的重大进展.
- 迫切需要提高围产期抑郁症的检测率和治疗可用性.
- 将心理健康护理纳入更广泛的系统对于优化母亲和婴儿的结果至关重要.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
260
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
260
Treatment Strategies for Psychological Disorders
149
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
149
Depression: Overview
263
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
263
Electroconvulsive Therapy
50
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
50
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
418
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
418
Drug Therapy
51
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
51


